Drimva

Cresilon

Director of Research & Development

$160K–$240K

Brooklyn, New York · Director · Full-time · Posted Sep 1, 2026

Experience
10+ years of direct management experience and 10+ years developing and using polymer or other complex materials.
Education
Bachelor’s degree in a listed or related discipline; a Ph.D. in a relevant discipline is strongly preferred.
Visa sponsorship
Legal authorization to work in the United States.

About the job

Leads Cresilon’s R&D team in developing, scaling, launching, and managing hemostasis products and processes for animal health and human markets.

What you'll do

  • Lead and develop multidisciplinary R&D staff and direct multiple product-development programs from early research through commercialization and lifecycle management.
  • Oversee research, technology transfer, scale-up, process validation, product testing, and compliance with specifications, SOPs, and FDA regulations.
  • Set technical strategy, manage budgets and schedules, and coordinate cross-functional teams, funding activities, and research publications.

What they ask for

  • Bachelor’s degree in Chemical Engineering, Materials Science & Engineering, Mechanical Engineering, Biomedical Engineering, Chemistry, or a related discipline.
  • 10+ years of direct management experience.
  • 10+ years developing and using polymer materials, chemistries, or other complex materials for product/application development and manufacture.
  • Demonstrated success leading projects from early development through stage-gate milestones, regulatory submission, and commercial launch.

Nice to have

  • Ph.D. in a relevant discipline.
  • Experience leading regulated medical-device and delivery-system development from concept to market release.

Pay

$160,000 - $240,000 USD base salary

Tools

Microsoft Office, Microsoft Excel, Microsoft Word, Microsoft PowerPoint, 21 CFR Part 820, ISO 13485, cGMP, ICH guidelines

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)